MedTrace Logo

Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant

NCT03116997 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2025-05-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare two different medications (neostigmine/glycopyrrolate and sugammadex) to see if one drug improves patient comfort regarding the return of muscle strength after surgery.

Conditions

  • Surgery

Interventions

DRUG

Neostigmine+glycopyrrolate

At the conclusion of surgery neuromuscular blockade reversed with neostigmine/glycopyrrolate

DRUG

Sugammadex

At the conclusion of surgery neuromuscular blockade reversed with sugammadex

Sponsors & Collaborators

Principal Investigators

  • German Echeverry, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-07
Primary Completion
2022-03-03
Completion
2022-03-03
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03116997 on ClinicalTrials.gov